Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Houghten's lead CRA safe in diabetics

Dec. 5, 1996

Priority review for Crinone

Dec. 5, 1996

New nonoxynol-9 formulations tested at University of Kentucky

Dec. 4, 1996

Another Barr generic drug cleared by the FDA

Dec. 4, 1996

Alteon amends ACTION II trial

Dec. 4, 1996

Cholesterol-lowering activity reported for Yamanouchi LTD4 antagonist

Dec. 4, 1996

New bisphosphonic acid derivatives from Nippon Chemiphar

Dec. 4, 1996

Novel antiobesity drug filed for approval

Dec. 3, 1996

Osiris licenses inducing molecule involved in cartilage formation

Dec. 3, 1996

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.